379nok
8,6 %
Date:2025-11-07Time:18:00:00Latest report:Q2-2025List:Oslo GrowthTicker:ABS
Market Cap:96 mnokEnterprise Value:149 mnokNet Sales:44,0 mnokEarnings:-43,4 mnokEmployees:0ISIN:NO0010859580
Ratios
10-year key figure history for Arctic Bioscience turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Arctic Bioscience with index and moving average MA50 and MA200.
Stockprice:3,79
MA50:3,55
MA200:3,68
Price/MA200:3,1 %
RSI (14):57,9
Price/MA50:6,7 %
Description
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a novel drug candidate for the treatment of patients with mild to moderate psoriasis. Dietary supplements are sold globally as both bulk ingredients and finished products under the ROMEGA brand, to both companies and private customers.